Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/517,612external-prioritypatent/US4485107A/en
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of FI882445ApublicationCriticalpatent/FI882445A/fi
Publication of FI882445A0publicationCriticalpatent/FI882445A0/fi
Publication of FI83078BpublicationCriticalpatent/FI83078B/fi
Application grantedgrantedCritical
Publication of FI83078CpublicationCriticalpatent/FI83078C/fi
Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara /2-(4-difenylmetylen)-1-piperidinyl/etyl-tiazolo- och 2,3-dihydrotiazolo/3,2-a/pyrimidin-5-oner och -3,4-dihydropyrimido/2,1-b//1,3/tiazin-6-oner.
Nya kefalosporiner, foerfarande foer deras framstaellning, dessa innehaollande antibakteriellt aemne, mellanprodukter daerav samt foerfarande foer framstaellning av mellanprodukterna.